Yet despite decades of research, no treatment has been created that arrests Alzheimer’s cognitive deterioration, let alone reverses it. That dismal lack of progress is partly because of the infinite ...

Mass General Brigham “One of the main limitations in the field of Alzheimer’s disease research and treatment is that it is extremely difficult to design medications that can pass the blood ...

The FDA has granted medical manufacturer Beckman Coulter a Breakthrough Device Designation for its new plasma ratio, a blood ...

Poorkaj, G. Schellenberg, R. Tanzi, W. Wasco, L. Lannfelt, D. Selkoe, S. Younkin, "Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by ...

Taking too long to enter the phase of sleep in which we dream may be an early sign of Alzheimer's disease. This is the conclusion of an international team of researchers who studied the sleep ...

“One of the main limitations in the field of Alzheimer’s disease research and treatment is that it is extremely difficult to design medications that can pass the blood-brain barrier—but ...